Navigation Links
Lexicon to Present at Stifel Nicolaus Healthcare Conference
Date:9/9/2010

current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct preclinical and clinical development of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Lexicon to Present at Morgan Stanley Global Healthcare Conference
2. Lexicon to Present at Two Major Healthcare Investor Conferences
3. Lexicon Announces Pricing of Common Stock in Public Offering
4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial Results
5. Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
6. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
8. Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
9. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
10. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
11. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014 Caustic soda is utilized in the ... At present, China takes lead in the global caustic soda ... a number of facilities in the USA, Germany, Brazil and ... soda market in terms of output and production capacities. , ... average by 3% per year in the years ahead. The ...
(Date:10/31/2014)... October 31, 2014 This is ... and China Biocides industry. The report provides basic ... industry chain structure as well as industry overview. ... China’s domestic market as well as Global industry ... The report on the Chinese biocides industry ...
(Date:10/31/2014)... 2014  Tavistock Development Co. (TDC), a diversified ... groundbreaking of the GuideWell Innovation Center ... The 92,000-square-foot, three-story facility is the first multi-tenant ... designed specifically for life sciences, health innovation, and ... 650-acre Lake Nona Medical City, near the Sanford-Burnham ...
(Date:10/30/2014)... (PRWEB) October 29, 2014 Global polyvinyl ... the world economic crisis during 2008-2009, especially in North ... recovered and currently is keeping to a growing trend. ... volume is utilized in the construction segment. In 2013, ... pipes, profiles, tubing, sheets and rigid film. Moreover, the ...
Breaking Biology Technology:China to Dominate Caustic Soda Market Through 2018, Says Merchant Research & Consulting in Its New Study 2Biocides Market for International & Chinese Regional Development Analysis Now Available at DeepResearchReports.com 2Biocides Market for International & Chinese Regional Development Analysis Now Available at DeepResearchReports.com 3GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 2GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 3Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 2Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 3
... , 3Q09 Corporate Highlights: ... Astellas Pharma Europe Ltd. Made significant progress in ... Sales; Senior Director, Marketing; and Director, Commercial Operations Appointed ... chairman , Upcoming 2009 Milestones: ...
... . . . Fuel economy ratings for ... the www.fueleconomy.gov web site, which Oak Ridge National ... and the U.S. Environmental Protection Agency. Nine of the top ... electrics, led by the Toyota Prius (51 MPG city; 48 ...
... 5 ThermoGenesis Corp. (Nasdaq: KOOL ), a leading ... cells, today reported results for the first quarter of fiscal ... Company reported revenues of $5.2 million, a 15 percent increase ... year ago. The Company said the key contributors to the ...
Cached Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
(Date:10/30/2014)... professor has received a $1.04 million grant from ... tissue and reduce osteoarthritis using a patient,s own ... made of biodegradable polymers., Liping Tang, a bioengineering ... said the research is primarily focused on helping ... "We,ve found that if we inject microscaffolding that ...
(Date:10/30/2014)... available in German . ... our fellow humans to behave socially? This is one ... game theory. Previous studies assumed that it is almost ... from the Max Planck Institute for Evolutionary Biology have ... influence on the cooperative behaviour of others. However, the ...
(Date:10/30/2014)... Bacteria in the gastrointestinal tract fulfill many vital ... same bacteria can induce strong inflammatory responses by ... and enter the bloodstream. , Although acute inflammation ... chronic or systemic inflammation is linked to numerous ... involvement of inflammatory processes in the development of ...
Breaking Biology News(10 mins):UTA researcher uses microscaffolding injections to mend cartilage, prevent osteoarthritis 2Together we are strong -- or insufferable 2Together we are strong -- or insufferable 3Together we are strong -- or insufferable 4Breakdown in gut barriers to bacteria may promote inflammation and craving in alcoholics 2
... population in Canada, but the statistics are even more ... a study published recently in the American Journal of ... to 65 per cent of Cree preschoolers in northern ... Willows, a community nutritionist at the University of Alberta, ...
... potential has so far gone largely untapped. But new research ... shows that adult stem cells taken from skin can be ... The findings are reported in the Feb. 12 online edition ... Embryonic stem cells have received the most press for their ...
... the April 15th issue of Genes & Development, Dr. ... the minimal DNA structure sufficient to activate the ATR-mediated ... about these results," says Dr. Cimprich. "The ability to ... activating structure in an experimental system will enable us ...
Cached Biology News:Scientists clone mice from adult skin stem cells 2Scientists clone mice from adult skin stem cells 3
BD BioCoat Fibronectin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of human fibronectin....
... Cytokeratin TYPE II Reacts with most ... epidermal cell keratin of 86 and 58kD ... Broad keratin reactivity is found on human ... Immunogen: Human epidermal cells ...
BD BioCoat Fibronectin 150 mm Culture Dishes...
... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ... assistance. ID clarifier: tissue-culture treated ... cm 2 D H 245 ...
Biology Products: